Br J Psychiatry

1. FERNANDEZ-EGEA E, Flanagan RJ, Taylor D, Gaughran F, et al
   Mortality associated with clozapine: what is the evidence?
   Br J Psychiatry. 2024;225:357-359.
   

   >> Share

   
   

   
   Can J Psychiatry

2. ALARABI M, Burton L, Powell V, Isinger T, et al
   Formal Thought Disorders and Neurocognition in Treatment-Resistant Schizophrenia: Trouble du cours de la pensee et neurocognition dans la schizophrenie refractaire.
   Can J Psychiatry. 2024 Nov 4:7067437241293985. doi: 10.1177/07067437241293985.
   

   >> Share

   
   
3. BARBER S, Mulushoa A, Hanlon C, Malla A, et al
   Psychosis and Gender: A Focus on Women in the Global South.
   Can J Psychiatry. 2024 Nov 3:7067437241295301. doi: 10.1177/07067437241295301.
   

   >> Share

   
   

   
   Compr Psychiatry

4. CASTELEIN S, Visser E, Brilman MF, Wardenaar KJ, et al
   Identifying factors strongest associated with clinical, societal and personal recovery in people with psychosis with a long duration of illness.
   Compr Psychiatry. 2024;136:152540.
   

   >> Share

   
   

   
   Cortex

5. SHARPLESS BA, Blom JD
   Cotard's syndrome before Cotard: A commentary on : Delusions in postpartum psychosis: Implications for cognitive theories.
   Cortex. 2024 Oct 22:S0010-9452(24)00258-2. doi: 10.1016/j.cortex.2024.
   

   >> Share

   
   

   
   Mol Psychiatry

6. SOCRATES AJ, Mullins N, Gur RC, Gur RE, et al
   Polygenic risk of social isolation behavior and its influence on psychopathology and personality.
   Mol Psychiatry. 2024;29:3599-3606.
   

   >> Share

   
   
7. LUO J, Li L, Niu M, Kong D, et al
   Genetic regulation of human brain proteome reveals proteins implicated in psychiatric disorders.
   Mol Psychiatry. 2024;29:3330-3343.
   

   >> Share

   
   

   
   Neuropsychopharmacology

8. ZHANG W, Wang L, Wu X, Yao L, et al
   Improved patient identification by incorporating symptom severity in deep learning using neuroanatomic images in first episode schizophrenia.
   Neuropsychopharmacology. 2024 Nov 6. doi: 10.1038/s41386-024-02021.
   

   >> Share

   
   

   
   Neurosci Lett

9. AGOSTONI G, Bischetti L, Repaci F, Bechi M, et al
   The cognitive architecture of verbal humor in schizophrenia.
   Neurosci Lett. 2023 Oct 27:137541. doi: 10.1016/j.neulet.2023.137541.
   

   >> Share

   
   

   
   PLoS Genet

10. FU S, Wheeler W, Wang X, Hua X, et al
    A comprehensive framework for trans-ancestry pathway analysis using GWAS summary data from diverse populations.
    PLoS Genet. 2024;20:e1011322.
    

    >> Share

    
    

    
    PLoS One

11. WANG B, Zhou Y, Yu H, Jiang T, et al
    Correlations between nutritional indicators and cognitive function in patients with stable schizophrenia in a hospital setting.
    PLoS One. 2024;19:e0312227.
    

    >> Share

    
    

    
    Psychiatry Res

12. DEMIRLEK C, Verim B, Zorlu N, Demir M, et al
    Functional brain networks in clinical high-risk for bipolar disorder and psychosis.
    Psychiatry Res. 2024;342:116251.
    

    >> Share

    
    
13. CALZAVARA PINTON I, Nibbio G, Bertoni L, Cicale A, et al
    The economic burden of schizophrenia spectrum disorders: clinical and functional correlates and predictors of direct costs. A retrospective longitudinal study.
    Psychiatry Res. 2024;342:116240.
    

    >> Share

    
    

    
    Schizophr Res

14. XU L, Yang W, Fan R, Wu Y, et al
    A novel digital intervention for improving cognitive impairment in patients with chronic schizophrenia: A randomized clinical trial.
    Schizophr Res. 2024;274:433-440.
    

    >> Share

    
    
15. YAEGASHI H, Haga M, Misawa F, Mizuno Y, et al
    Intentional non-adherence to antipsychotic medication in patients with schizophrenia.
    Schizophr Res. 2024;274:427-432.
    

    >> Share

    
    
16. LAMSMA J, Harte JM, Cahn W
    Risk factors for violent behaviour before and after the onset of schizophrenia spectrum disorder: A naturalistic case-control study in the Netherlands.
    Schizophr Res. 2023;262:1-7.
    

    >> Share

    
    
17. ABDULLAHI A, Wong TW, Ng SS
    Understanding the potential mechanisms of disease modifying effects of physical activity and exercise in people with schizophrenia.
    Schizophr Res. 2024;274:381-391.
    

    >> Share

    
    
18. TIAN J, Dong S, Nomura N, Siafis S, et al
    Efficacy and tolerability of blonanserin in schizophrenia: A systematic review and meta-analysis of randomized controlled trials.
    Schizophr Res. 2024;274:360-373.
    

    >> Share

    
    
19. LI S, Lu C, Liu N, Li Y, et al
    Association between auditory P300 event-related potential and suicidal thoughts and behaviors in first-episode antipsychotic-naive patients with schizophrenia.
    Schizophr Res. 2024;274:352-359.
    

    >> Share

    
    
20. ALI MP, Tiles-Sar N, Simons CJP, Osicka DA, et al
    Does stigma leave its mark? The interplay between negative effects of perceived stigma with positive effect of self-esteem on long-term social functioning in schizophrenia.
    Schizophr Res. 2024;274:417-426.
    

    >> Share

    
    
21. ANDERSON JC, Seitz DP, Crockford D, Addington D, et al
    Quality indicators for schizophrenia care: A scoping review.
    Schizophr Res. 2024;274:406-416.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share